Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 1, 2010, Pages 37-46

  Gomez, Diana I ^a   Fisher Hoch, Susan P ^a   Bordt, Andrea S ^a   Quitugua, Teresa N ^b   Robledo, Jaime ^c   Alvarez, Nataly ^c   Correa, Nidia ^c   McCormick, Joseph B ^a   Restrepo, Blanca I ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Texas Health Science Center   (United States)

^c Corporación para Investigaciones Biológicas ^*  (Colombia)

Author keywords

Colombia; MDR TB; Molecular beacon; Mycobacterium; Real time polymerase chain reaction; Rifampicin resistance; Texas Mexico border; Tuberculosis

Indexed keywords

BACTERIAL DNA; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BASE PAIRING; CONTROLLED STUDY; DNA SEQUENCE; GENE IDENTIFICATION; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MOLECULAR BEACON; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; READING; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; WILD TYPE;

ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; COLOMBIA; HUMANS; MEXICO; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TEXAS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77951497849     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.12.007     Document Type: Article

References (32)

1. Ahmad S., Araj G.F., Akbar P.K., Fares E., Chugh T.D., Mustafa A.S. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn. Microbiol. Infect. Dis. 2000, 38:227-232.
2. Ahmad S., Mokaddas E. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int. J. Antimicrob. Agents 2005, 26:205-212.
3. Bartfai Z., Somoskovi A., Kodmon C., Szabo N., Puskas E., Kosztolanyi L., Farago E., Mester J., Parsons L.M., Salfinger M. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 2001, 39:3736-3739.
4. Cavusoglu C., Hilmioglu S., Guneri S., Bilgic A. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol. 2002, 40:4435-4438.
5. Cooksey R.C., Morlock G.P., Glickman S., Crawford J.T. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 1997, 35:1281-1283.
6. Eickbush T.H., Moudrianakis E.N. The compaction of DNA helices into either continuous supercoils or folded-fiber rods and toroids. Cell 1978, 13:295-306.
7. El-Hajj H.H., Marras S.A., Tyagi S., Kramer F.R., Alland D. Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J. Clin. Microbiol. 2001, 39:4131-4137.
8. Heid C.A., Stevens J., Livak K.J., Williams P.M. Real time quantitative PCR. Genome Res. 1996, 6:986-994.
9. Hirano K., Abe C., Takahashi M. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J. Clin. Microbiol. 1999, 37:2663-2666.
10. Hoek K.G., Gey van Pittius N.C., Moolman-Smook H., Carelse-Tofa K., Jordaan A., van der Spuy G.D., Streicher E., Victor T.C., van Helden P.D., Warren R.M. Fluorometric assay for testing rifampin susceptibility of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 2008, 46:1369-1373.
11. Jureen P., Engstrand L., Eriksson S., Alderborn A., Krabbe M., Hoffner S.E. Rapid detection of rifampin resistance in Mycobacterium tuberculosis by pyrosequencing technology. J. Clin. Microbiol. 2006, 44:1925-1929.
12. Kent P.T., Kubica G.P. Public health mycobacteriology: a guide for the level III laboratory 1985, Center for Disease Control and Prevention, Atlanta, GA.
13. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
14. Lin S.-Y.G., Probert W., Lo M., Desmond E. Rapid detection of isoniazid and rifampin resistance mutations in Mycobacterium tuberculosis complex from cultures or smear-positive sputa by use of molecular beacons. J. Clin. Microbiol. 2004, 42:4204-4208.
15. Matsiota-Bernard P., Vrioni G., Marinis E. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol. 1998, 36:20-23.
16. McCammon M.T., Gillette J.S., Thomas D.P., Ramaswamy S.V., Graviss E.A., Kreiswirth B.N., Vijg J., Quitugua T.N. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob. Agents Chemother. 2005, 49:2200-2209.
17. Nikolayevskyy V.V., Brown T.J., Bazhora Y.I., Asmolov A.A., Balabanova Y.M., Drobniewski F.A. Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine. Clin. Microbiol. Infect. 2007, 13:129-138.
18. Ozkutuk N., Gazi H., Surucuoglu S., Gunduz A., Ozbakkaloglu B. Characterization of rpoB mutations by line probe assay in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from the Aegean region in Turkey. Jpn. J. Infect. Dis. 2007, 60:211-213.
19. Palomino J.C. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr. Opin. Pulm. Med. 2006, 12:172-178.
20. Piatek A.S., Telenti A., Murray M.R., El-Hajj H., Jacobs W.R., Kramer F.R., Alland D. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 2000, 44:103-110.
21. Piatek A.S., Tyagi S., Pol A.C., Telenti A., Miller L.P., Kramer F.R., Alland D. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat. Biotechnol. 1998, 16:359-363.
22. Quitugua T.N., Seaworth B.J., Weis S.E., Taylor J.P., Gillette J.S., Rosas I.I., Jost K.C., Magee D.M., Cox R.A. Transmission of drug-resistant tuberculosis in Texas and Mexico. J. Clin. Microbiol. 2002, 40:2716-2724.
23. Robledo J., Mejia G.I., Paniagua L., Martin A., Guzman A. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method. Int. J. Tuberc. Lung Dis. 2008, 12:1482-1484.
24. Somoskovi A., Parsons L.M., Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2001, 2:164-168.
25. Stop TB Partnership and World Health Organization The global plan to stop TB, 2006-2015 2006, Stop TB Partnership; World Health Organization, Geneva, WHO/HTM/STB/2006.35. http://www.stoptb.org/globalplan.
26. Stop TB Partnership and World Health Organization New laboratory diagnostic tools for tuberculosis control WHO/HTM/STB/2008.49. http://www.finddiagnostics.org/export/sites/default/resource-centre/reports_brochures/docs/New_Lab_Diagnostic_Tools_forTB.pdf.
27. Tyagi S., Kramer F.R. Molecular beacons: probes that fluoresce upon hybridization. Nat. Biotechnol. 1996, 14:303-308.
28. van Soolingen D., Hermans P.W., de Haas P.E., Soll D.R., van Embden J.D. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 1991, 29:2578-2586.
29. Varma-Basil M., El-Hajj H., Colangeli R., Hazbon M.H., Kumar S., Bose M., Bobadilla-del-Valle M., Garcia L.G., Hernandez A., Kramer F.R., Osornio J.S., Ponce-De-Leon A., Alland D. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J. Clin. Microbiol. 2004, 42:5512-5516.
30. World Health Organization Anti-tuberculosis drug resistance in the world. Fourth Global Report WHO/HTM/TB/2008.394. http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf.
31. World Health Organization Global tuberculosis control: surveillance, planning, financing 1-1-2003. http://www.who.int/tb/publications/global_report/2009/en/index.html.
32. World Health Organization Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009 2009, World Health Organization, Geneva, WHO/HTM/TB/2009.411. http://www.who.int/tb/publications/global_report/2009/en/index.html.